Phase 1 Trial of a Monoclonal Antibody to OX40 in Patients With Advanced Cancer.

Trial Profile

Phase 1 Trial of a Monoclonal Antibody to OX40 in Patients With Advanced Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Jun 2017

At a glance

  • Drugs MEDI 6469 (Primary) ; Keyhole limpet haemocyanin; Tetanus vaccine
  • Indications Cancer; Lymphoma
  • Focus Adverse reactions
  • Most Recent Events

    • 13 Jun 2017 Status changed from active, no longer recruiting to completed.
    • 26 Sep 2016 Planned End Date changed from 1 Jan 2015 to 1 Jan 2017.
    • 27 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top